Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

COVID19 Update

Publications

  • InnovationMap Houston
    Houston biotech company gets green light from FDA to test coronavirus-fighting drug


  • Press Release
    Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19


  • Clinical Trials.gov https://www.clinicaltrials.gov/ct2/show/NCT04312997

     

  • Houston Chronicle
    Houston researchers test lung inhalant that could protect healthcare workers from COVID-19

     

  • Houston Business Journal
    Houston biotech co.’s coronavirus treatment candidate to undergo clinical trials

in the news

  • ABC 13 Houston
    Coronavirus
    protection drug approved by FDA for testing in Houston

  • Wall Street Journal Pro
    Serendipity Propels Verge Genomics Into Race for Covid-19 Drug (Subscription Required)

  • ABC 13 Houston
    Houston company testing drug to protect against COVID-19

  • Fox 26 Houston
    Houston company working on possible COVID-19 treatment
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2025
Pulmotect, Inc.